Basic residues in the foamy virus Gag protein

Journal of Virology

Volumn 85, Issue 8, 2011, Pages 3986-3995

  Matthes, Daniel ^a   Wiktorowicz, Tatiana ^a   Zahn, Juliane ^a   Bodem, Jochen ^a   Stanke, Nicole ^b   Lindemann, Dirk ^b   Rethwilm, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD317 ANTIGEN; GAG PROTEIN; INTERFERON; LYMPHOCYTE ANTIGEN; LYSINE; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; AMINO ACID SUBSTITUTION; ARTICLE; CELL CULTURE; CODON; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOTYPING; REVERSE TRANSCRIPTION; SPUMA VIRUS; UBIQUITINATION; VIRION; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS GENOME; VIRUS LIKE AGENT; VIRUS MUTATION; VIRUS REPLICATION;

AMINO ACIDS, BASIC; GENE PRODUCTS, GAG; MUTAGENESIS, SITE-DIRECTED; SPUMAVIRUS; VIRULENCE; VIRUS REPLICATION;

HUMAN SPUMARETROVIRUS; MIRIDAE;

EID: 79952846238     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01906-10     Document Type: Article

References (77)

1. Adachi, A., et al. 1987. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61:209-213. (Pubitemid 17212464)
2. Ausubel, F. M., et al. 1987. Current protocols in molecular biology. John Wiley, New York, NY.
3. Bender, A., G. G. van Dooren, S. A. Ralph, G. I. McFadden, and G. Schneider. 2003. Properties and prediction of mitochondrial transit peptides from Plasmodium falciparum. Mol. Biochem. Parasitol. 132:59-66.
4. Bock, M., K. N. Bishop, G. Towers, and J. P. Stoye. 2000. Use of a transient assay for studying the genetic determinants of Fv1 restriction. J. Virol. 74:7422-7430.
5. Bosch, V., and M. Pawlita. 1990. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 64:2337-2344. (Pubitemid 20148482)
6. Cartellieri, M., et al. 2005. N-terminal Gag domain required for foamy virus particle assembly and export. J. Virol. 79:12464-12476. (Pubitemid 41346109)
7. Chen, Y., et al. 2007. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell Proteomics 6:812-819. (Pubitemid 46831933)
8. Cullen, B. R. 2006. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80:1067-1076. (Pubitemid 43134064)
9. Delebecque, F., et al. 2006. Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 80:605-614. (Pubitemid 43062873)
10. Derdeyn, C. A., et al. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358-8367. (Pubitemid 30666686)
11. DuBridge, R. B., et al. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
12. Eastman, S. W., and M. L. Linial. 2001. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J. Virol. 75:6857-6864.
13. Enssle, J., et al. 1997. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J. Virol. 71:7312-7317. (Pubitemid 27391669)
14. Evans, D. T., R. Serra-Moreno, R. K. Singh, and J. C. Guatelli. 2010. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18:388-396.
15. Falcone, V., M. Schweizer, A. Toniolo, D. Neumann-Haefelin, and A. Meyerhans. 1999. Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects. J. Virol. 73:1724-1728. (Pubitemid 29036838)
16. Fischer, N., et al. 1998. Foamy virus particle formation. J. Virol. 72:1610-1615.
17. Flügel, R. M., and K. I. Pfrepper. 2003. Proteolytic processing of foamy virus Gag and Pol proteins. Curr. Top. Microbiol. Immunol. 277:63-88.
18. Gattenloehner, S., et al. 2007. Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression. Blood 110: 2027-2033. (Pubitemid 47443919)
19. Giron, M. L., S. Colas, J. Wybier, F. Rozain, and R. Emanoil-Ravier. 1997. Expression and maturation of human foamy virus Gag precursor polypeptides. J. Virol. 71:1635-1639. (Pubitemid 27030341)
20. Heinkelein, M., et al. 2002. Improved primate foamy virus vectors and packaging constructs. J. Virol. 76:3774-3783. (Pubitemid 34250542)
21. Higuchi, R. 1990. Recombinant PRC, p. 177-183. In M. A. Innis, D. H. Gelfand, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, CA.
22. Hunter, E. 1997. Viral entry and receptors, p. 71-121. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. Jacobs, J. P., C. M. Jones, and J. P. Baille. 1970. Characteristics of a human diploid cell designated MRC-5. Nature 227:168-170.
24. Jouvenet, N., et al. 2009. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83:1837-1844.
25. Katzourakis, A., R. J. Gifford, M. Tristem, M. T. Gilbert, and O. G. Pybus. 2009. Macroevolution of complex retroviruses. Science 325:1512.
26. Lefrancois, L., and D. S. Lyles. 1982. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121:157-167.
27. Lefrancois, L., and D. S. Lyles. 1982. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes. Virology 121:168-174.
28. Lehmann-Che, J., et al. 2005. Protease-dependent uncoating of a complex retrovirus. J. Virol. 79:9244-9253. (Pubitemid 40934836)
29. Life, R. B., E. G. Lee, S. W. Eastman, and M. L. Linial. 2008. Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly. J. Virol. 82:6109-6119.
30. Lindemann, D., and P. A. Goepfert. 2003. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 277:111-129.
31. Lindemann, D., et al. 2001. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 75:5762-5771. (Pubitemid 32553108)
32. Linial, M. L. 2007. Foamy viruses. Lippincott Williams & Wilkins, Philadelphia, PA.
33. Linial, M. L., et al. 2005. Retroviridae, p. 421-440. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy: classification and nomenclature of viruses. Eighth report of the International Committee on Taxonomy of Viruses. Elsevier/Academic Press, London, United Kingdom.
34. Löchelt, M., et al. 2005. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U. S. A. 102:7982-7987.
35. Mannigel, I., A. Stange, H. Zentgraf, and D. Lindemann. 2007. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J. Virol. 81:3317-3326. (Pubitemid 46456640)
36. Martin-Serrano, J. 2007. The role of ubiquitin in retroviral egress. Traffic 8:1297-1303. (Pubitemid 47394235)
37. Meiering, C. D., and M. L. Linial. 2001. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14:165-176.
38. Moebes, A., et al. 1997. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:7305-7311. (Pubitemid 27391668)
39. Neil, S. J., T. Zang, and P. D. Bieniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
40. Nisole, S., J. P. Stoye, and A. Saib. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799-808.
41. Patton, G. S., S. A. Morris, W. Chung, P. D. Bieniasz, and M. O. McClure. 2005. Identification of domains in Gag important for prototypic foamy virus egress. J. Virol. 79:6392-6399.
42. Perkovic, M., et al. 2009. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 284:5819-5826.
43. Petit, C., et al. 2003. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J. Cell Sci. 116:3433-3442. (Pubitemid 37038990)
44. Pfrepper, K. I., et al. 1999. Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus. J. Virol. 73:7907-7911.
45. Pietschmann, T., et al. 1999. Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73:2613-2621. (Pubitemid 29135645)
46. Pincetic, A., and J. Leis. 2009. The mechanism of budding of retroviruses from cell membranes. Adv. Virol. 2009:6239691-6239699.
47. Rasheed, S., W. A. Nelson-Rees, E. M. Toth, P. Arnstein, and M. B. Gardner. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
48. Rethwilm, A. 2007. Foamy virus vectors: an awaited alternative to gamma-retro- and lentiviral vectors. Curr. Gene Ther. 7:261-271.
49. Rethwilm, A. 2003. The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 277:1-26.
50. Rhodes-Feuillette, A., et al. 1990. Effects of human recombinant alpha and gamma and of highly purified natural beta interferons on simian Spumavirinae prototype (simian foamy virus 1) multiplication in human cells. Res. Virol. 141:31-43.
51. Rhodes-Feuillette, A., F. Saal, J. Lasneret, M. Santillana-Hayat, and J. Peries. 1987. Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses. Arch. Virol. 97:77-84.
52. Roy, J., et al. 2003. Feline foamy virus genome and replication strategy. J. Virol. 77:11324-11331. (Pubitemid 37271631)
53. Russell, R. A., et al. 2005. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 79:8724-8731. (Pubitemid 40934783)
54. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
55. Schliephake, A. W., and A. Rethwilm. 1994. Nuclear localization of foamy virus Gag precursor protein. J. Virol. 68:4946-4954. (Pubitemid 24226560)
56. Schmidt, M., and A. Rethwilm. 1995. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 210:167-178.
57. Schweizer, M., and D. Neumann-Haefelin. 1995. Phylogenetic analysis of primate foamy viruses by comparison of Pol sequences. Virology 207:577-582.
58. Seeger, C., F. Zoulim, and W. S. Mason. 2007. Hepadnaviruses, p. 2977-3029. In D. M. Knipe et al. (ed.), Fields virology, 5th ed. Lippincott Williams, Philadelphia, PA.
59. Soneoka, Y., et al. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
60. Song, B., et al. 2005. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 79:3930-3937. (Pubitemid 40388333)
61. Stange, A., et al. 2005. Characterization of prototype foamy virus Gag late assembly domain motifs and their role in particle egress and infectivity. J. Virol. 79:5466-5476. (Pubitemid 40548215)
62. Stanke, N., A. Stange, D. Luftenegger, H. Zentgraf, and D. Lindemann. 2005. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J. Virol. 79:15074-15083. (Pubitemid 43032289)
63. Stirnnagel, K., et al. 2010. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 7:45.
64. Strack, B., A. Calistri, and H. G. Gottlinger. 2002. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J. Virol. 76:5472-5479.
65. Switzer, W. M., et al. 2005. Ancient co-speciation of simian foamy viruses and primates. Nature 434:376-380. (Pubitemid 40469179)
66. Tobaly-Tapiero, J., et al. 2001. Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J. Virol. 75:4367-4375. (Pubitemid 32410148)
67. Tobaly-Tapiero, J., et al. 2008. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 9:1717-1727.
68. Towers, G. J. 2007. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology. 4:40.
69. Verschoor, E. J., et al. 2004. The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of Sumatra. J. Virol. 78:12712-12716. (Pubitemid 39458794)
70. Walsh, C. T., S. Garneau-Tsodikova, and G. J. Gatto, Jr. 2005. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl. 44:7342-7372.
71. Wiktorowicz, T., K. Peters, N. Armbruster, A. F. Steinert, and A. Rethwilm. 2009. Generation of an improved foamy virus vector by dissection of cisacting sequences. J. Gen. Virol. 90:481-487.
72. Wurm, M., et al. 2010. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J. Gene Med. 12:137-146.
73. Yap, M. W., et al. 2008. Restriction of foamy viruses by primate Trim5α. J. Virol. 82:5429-5439. (Pubitemid 351705250)
74. Yu, S. F., et al. 1996. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 70:8255-8262. (Pubitemid 26378399)
75. Yu, S. F., M. D. Sullivan, and M. L. Linial. 1999. Evidence that the human foamy virus genome is DNA. J. Virol. 73:1565-1572.
76. Zemba, M., et al. 1998. The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology 247:7-13. (Pubitemid 28384020)
77. Zhadina, M., M. O. McClure, M. C. Johnson, and P. D. Bieniasz. 2007. Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc. Natl. Acad. Sci. U. S. A. 104:20031-20036.